Brief: Transcode Therapeutics Announces Positive Pre-Clinical Glioblastoma Results With Lead Therapeutic Candidate, Ttx-Mc138
25/09/2023 13:36
Sept 25 (Reuters) - Transcode Therapeutics Inc RNAZ.O :
* TRANSCODE THERAPEUTICS ANNOUNCES POSITIVE PRE-CLINICAL
GLIOBLASTOMA RESULTS WITH LEAD THERAPEUTIC CANDIDATE, TTX-MC138
Source text for Eikon: ID:nGNXKZHfX
Further company coverage: RNAZ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Transcode Therapeutics
See all newsBrief: TransCode Therapeutics Appoints John Tattory As Interim CFO
Brief: Transcode Therapeutics Appoints Dr. Anna Moore As Chair Of Scientific Advisory Board
Brief: Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash
Brief: Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026
Brief: Transcode Therapeutics Expands Leadership With Appointment Of Jack E. Stover To Board Of Directors